The role of GTPase-activating protein ARHGAP26 in human cancers.

Mol Cell Biochem

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Digestive Disease center, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing, China.

Published: January 2022

Rho GTPases are molecular switches that play an important role in regulating the behavior of a variety of tumor cells. RhoA GTPase-activating protein 26 (ARHGAP26) is a GTPase-activating protein and inhibits the activity of Rho GTPases by promoting the hydrolytic ability of Rho GTPases. It also affects tumorigenesis and progression of various tumors through several methods, including formation of abnormal fusion genes and circular RNA. This review summarizes the biological functions and molecular mechanisms of ARHGAP26 in different tumors, proposes the potential clinical value of ARHGAP26 in cancer treatment, and discusses current issues that need to be addressed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755663PMC
http://dx.doi.org/10.1007/s11010-021-04274-3DOI Listing

Publication Analysis

Top Keywords

gtpase-activating protein
12
rho gtpases
12
protein arhgap26
8
role gtpase-activating
4
arhgap26
4
arhgap26 human
4
human cancers
4
cancers rho
4
gtpases molecular
4
molecular switches
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!